Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
British Journal of Cancer
|
April 8, 2021
A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer
Dae Won Kim, Elaine Tan, Jun-Min Zhou, et al.
American Journal of Clinical Oncology
|
February 7, 2020
Determining Optimal Follow-up for Patients With Anal Cancer Following Chemoradiation
Marissa L Frazer, George Yang, Seth Felder, et al.
Cancer
|
June 1, 2016
Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers
Nishi Kothari, Jamie K Teer, Andrea M Abbott, et al.
JAMA Network Open
|
March 20, 2025
Practice Patterns and Survival Outcomes of Immunotherapy for Metastatic Colorectal Cancer
Shahla Bari, Marco Matejcic, Richard D Kim, et al.
American Journal of Clinical Oncology
|
November 3, 2015
Clinical Outcomes of Patients With Gastrointestinal Malignancies Participating in Phase I Clinical Trials
Aaron Denson, Nancy Burke, Georgine Wapinsky, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2022
A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer
Richard D Kim, Bence P Kovari, Maria Martinez, et al.
JAMA Network Open
|
June 26, 2023
Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal Cancer
Lingbin Meng, Ram Thapa, Maria G Delgado, et al.
JAMA Oncology
|
May 1, 2020
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer
Richard D Kim, Vincent Chung, Olatunji B Alese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2020
Phase II Study of Ensituximab, a Novel Chimeric Monoclonal Antibody, in Adults with Unresectable, Metastatic Colorectal Cancer
Richard D Kim, Nilofer S Azad, Michael A Morse, et al.
Cancers
|
June 13, 2025
Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study
Maen Abdelrahim, Abdullah Esmail, Richard D Kim, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
British Journal of Cancer
|
April 8, 2021
A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer
Dae Won Kim, Elaine Tan, Jun-Min Zhou, et al.
American Journal of Clinical Oncology
|
February 7, 2020
Determining Optimal Follow-up for Patients With Anal Cancer Following Chemoradiation
Marissa L Frazer, George Yang, Seth Felder, et al.
Cancer
|
June 1, 2016
Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers
Nishi Kothari, Jamie K Teer, Andrea M Abbott, et al.
JAMA Network Open
|
March 20, 2025
Practice Patterns and Survival Outcomes of Immunotherapy for Metastatic Colorectal Cancer
Shahla Bari, Marco Matejcic, Richard D Kim, et al.
American Journal of Clinical Oncology
|
November 3, 2015
Clinical Outcomes of Patients With Gastrointestinal Malignancies Participating in Phase I Clinical Trials
Aaron Denson, Nancy Burke, Georgine Wapinsky, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2022
A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer
Richard D Kim, Bence P Kovari, Maria Martinez, et al.
JAMA Network Open
|
June 26, 2023
Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal Cancer
Lingbin Meng, Ram Thapa, Maria G Delgado, et al.
JAMA Oncology
|
May 1, 2020
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer
Richard D Kim, Vincent Chung, Olatunji B Alese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2020
Phase II Study of Ensituximab, a Novel Chimeric Monoclonal Antibody, in Adults with Unresectable, Metastatic Colorectal Cancer
Richard D Kim, Nilofer S Azad, Michael A Morse, et al.
Cancers
|
June 13, 2025
Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study
Maen Abdelrahim, Abdullah Esmail, Richard D Kim, et al.
Page
of 6